Characteristics | Â | Nectin-4 expression | P- value a | |
---|---|---|---|---|
 | Total n=123 | low n=54 (%) | high n=69 (%) |  |
Gender | Â | Â | Â | Â |
male | 72 | 30 (55.6) | 42 (60.9) | 0.584 |
female | 51 | 24 (44.4) | 27 (39.1) | Â |
Age, year | Â | Â | Â | Â |
< 66 | 59 | 27 (50.0) | 32 (46.4) | 0.690 |
>66 | 64 | 27 (50.0) | 37 (53.6) | Â |
Histopathological grading | Â | Â | Â | Â |
G1 | 34 | 13 (24.1) | 21 (30.4) | 0.873 |
G2 | 71 | 33 (61.1) | 38 (55.1) | Â |
G3 | 14 | 6 (11.1) | 8 (11.6) | Â |
G4 | 4 | 2 (3.7) | 2 (2.9) | Â |
Tumor status | Â | Â | Â | Â |
T1 | 8 | 4 (7.4) | 4 (5.8) | 0.299 |
T2 | 21 | 13 (24.1) | 8 (11.6) | Â |
T3 | 84 | 33 (61.1) | 51 (73.9) | Â |
T4 | 10 | 4 (7.4) | 6 (8.7) | Â |
Nodal status | Â | Â | Â | Â |
N0 | 50 | 24 (44.4) | 26 (37.7) | 0.466 |
N1 | 73 | 30 (55.6) | 43 (62.3) | Â |
Metastatic status | Â | Â | Â | Â |
M0 | 112 | 49 (90.7) | 63 (91.3) | >0.999b |
M1 | 11 | 5 (9.3) | 6 (8.7) | Â |
UICC stage | Â | Â | Â | Â |
IA, IB | 21 | 13 (24.1) | 8 (11.6) | 0.358 |
IIA | 26 | 10 (18.5) | 16 (23.2) | Â |
IIB | 60 | 25 (46.3) | 35 (507) | Â |
III | 5 | 1 (1.8) | 4 (5.8) | Â |
IV | 11 | 5 (9.3) | 6 (8.7) | Â |